Parkinson disease: New developments in CSF biomarkers for early detection and monitoring of Parkinson disease

被引:0
|
作者
Yates D.
机构
关键词
D O I
10.1038/nrneurol.2010.184
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [21] Association between CSF biomarkers and clinical phenotype of early Parkinson's disease in the Parkinson's Progression Marker Initiative (PPMI)
    Kang, J. H.
    Caspell, C.
    Coffey, C.
    Taylor, P.
    Frasier, M.
    Marek, K.
    Trojanowski, J. Q.
    Shaw, L. M.
    MOVEMENT DISORDERS, 2012, 27 : S34 - S35
  • [22] The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson's disease
    He, Peikun
    Gao, Yuyuan
    Shi, Lin
    Li, Yanyi
    Qiu, Yihui
    Feng, Shujun
    Tie, Zihui
    Gong, Liangxu
    Ma, Guixian
    Zhang, Yuhu
    Nie, Kun
    Wang, Lijuan
    PARKINSONISM & RELATED DISORDERS, 2024, 120
  • [23] Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers
    Linan, Victoria Soto
    Rioux, Veronique
    Peralta Iii, Modesto
    Dupre, Nicolas
    Hebert, Marc
    Levesque, Martin
    NEUROBIOLOGY OF DISEASE, 2025, 208
  • [24] The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers
    Paoletti, Federico Paolini
    Gaetani, Lorenzo
    Parnetti, Lucilla
    BIOMOLECULES, 2020, 10 (02)
  • [25] Blood Lipid Biomarkers in Early Parkinson's Disease and Parkinson's Disease with Mild Cognitive Impairment
    Deng, Xiao
    Saffari, Seyed Ehsan
    Ng, Samuel Yong Ern
    Chia, Nicole
    Tan, Jayne Yi
    Choi, Xinyi
    Heng, Dede Liana
    Xu, Zheyu
    Tay, Kay-Yaw
    Au, Wing-Lok
    Liu, Nan
    Ng, Adeline
    Tan, Eng-King
    Tan, Louis C. S.
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (06) : 1937 - 1943
  • [26] The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
    Bloem, B. R.
    Marks, W. J., Jr.
    Silva de Lima, A. L.
    Kuijf, M. L.
    van Laar, T.
    Jacobs, B. P. F.
    Verbeek, M. M.
    Helmich, R. C.
    van de Warrenburg, B. P.
    Evers, L. J. W.
    IntHout, J.
    van de Zande, T.
    Snyder, T. M.
    Kapur, R.
    Meinders, M. J.
    BMC NEUROLOGY, 2019, 19 (1)
  • [27] The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
    B. R. Bloem
    W. J. Marks
    A. L. Silva de Lima
    M. L. Kuijf
    T. van Laar
    B. P. F. Jacobs
    M. M. Verbeek
    R. C. Helmich
    B. P. van de Warrenburg
    L. J. W. Evers
    J. intHout
    T. van de Zande
    T. M. Snyder
    R. Kapur
    M. J. Meinders
    BMC Neurology, 19
  • [28] Biomarkers for cognitive decline of early Parkinson's disease
    Bereczki, E.
    Francis, P.
    Ballard, C.
    Hoglund, K.
    Svenningsson, P.
    Aarsland, D.
    MOVEMENT DISORDERS, 2014, 29 : S338 - S338
  • [29] Metabolomic Biomarkers in Early Parkinson's Disease.
    Umeh, C. C.
    Liao, Z.
    Dhima, K.
    Franco, D.
    Duong, K.
    Boot, B.
    Bayer, S.
    Trisini-Lipsanopoulos, A.
    Hyman, B. T.
    Dickerson, B.
    Growdon, J.
    Sudarsky, L.
    Sperling, R.
    Ivinson, A.
    Scherzer, C.
    MOVEMENT DISORDERS, 2014, 29 (10) : E7 - E7
  • [30] Shape Features as Biomarkers in Early Parkinson's Disease
    Prashanth, R.
    Roy, S. Dutta
    Ghosh, S.
    Mandal, Pravat K.
    2013 6TH INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING (NER), 2013, : 517 - 520